KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 99 filers reported holding KURA ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,405,000 | -9.5% | 822,500 | +0.7% | 0.32% | -3.9% |
| Q2 2021 | $17,030,000 | -15.2% | 816,800 | +15.0% | 0.34% | -23.1% |
| Q1 2021 | $20,073,000 | +21.0% | 710,035 | +39.7% | 0.44% | +24.4% |
| Q4 2020 | $16,595,000 | +134.1% | 508,116 | +25.5% | 0.35% | +37.0% |
| Q3 2018 | $7,088,000 | -2.6% | 405,000 | +1.2% | 0.26% | -8.2% |
| Q2 2018 | $7,280,000 | +1364.8% | 400,000 | +1409.4% | 0.28% | +1233.3% |
| Q1 2018 | $497,000 | – | 26,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |